7 Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus

Adachi, 1997, Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis, New England Journal of Medicine, 337, 382, 10.1056/NEJM199708073370603 Aranow, 1997, Clinically occult avascular necrosis of the hip in systemic lupus erythematosus, Journal of Rheumatology, 24, 2318 Askari, 1976, Steroid myopathy in connective tissue disease, American Journal of Medicine, 61, 485, 10.1016/0002-9343(76)90327-2 Becker, 1964, Cataracts and topical corticosteroids, American Journal of Ophthalmology, 58, 872, 10.1016/0002-9394(64)90810-4 Borba, 1997, Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies, Lupus, 6, 533, 10.1177/096120339700600610 Boumpas, 1991, Glucocorticosteroid action on the immune system: molecular and cellular aspects, Clinical and Experimental Rheumatology, 9, 413 Boyer, 1967, Hyperosmolar anacidotic coma in association with glucocorticoid therapy, Journal of the American Medical Association, 202, 1007, 10.1001/jama.1967.03130240049007 Bruce, 1997, Factors associated with myocardial perfusion abnormalities in women with SLE, Arthritis and Rheumatism, 40, S302 Budman, 1976, Hypertension and renal disease in systemic lupus erythematosus, Archives of Internal Medicine, 136, 1003, 10.1001/archinte.1976.03630090033009 Bulkley, 1975, The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients, American Journal of Medicine, 58, 243, 10.1016/0002-9343(75)90575-6 Burns, 1979, Cushing's syndrome, 1002 Buyon, 1995, Can women with systemic lupus erythematosus safely use exogenous estrogens?, Journal of Clinical Rheumatology, 1, 205, 10.1097/00124743-199508000-00002 Chambless, 1997, Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Athrosclerosis Risk in Communities (ARIC) study, American Journal of Epidemiology, 146, 483, 10.1093/oxfordjournals.aje.a009302 Chan, 1991, Danazol therapy in autoimmune hemolytic anemia associated with systemic lupus erythematosus, Journal of Rheumatology, 18, 280 Conn, 1976, Nonassociation of adrenocorticosteroid therapy and peptic ulcer, New England Journal of Medicine, 2954, 473, 10.1056/NEJM197602262940905 Conn, 1994, Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy, Journal of Internal Medicine, 236, 619, 10.1111/j.1365-2796.1994.tb00855.x Cordess, 1981, Psychiatric effects of alternate day steroid therapy, British Journal of Psychiatry, 138, 504, 10.1192/bjp.138.6.504 Cumming, 1997, Use of inhaled corticosteroids and the risk of cataracts, New England Journal of Medicine, 337, 46, 10.1056/NEJM199707033370102 Dhillon, 1990, Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry, Annals of the Rheumatic Diseases, 49, 624, 10.1136/ard.49.8.624 Dimant, 1978, Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE, Journal of Rheumatology, 5, 136 Dostal, 1990, The differential effect of corticosteroids on wound disruption strength in mice, Archives of Surgery, 125, 636, 10.1001/archsurg.1990.01410170084018 Dubois, 1956, Prednisone and prednisolone in the treatment of systemic lupus erythematosus, Journal of the American Medical Association, 161, 427, 10.1001/jama.1956.02970050029007 Ettinger, 1987, Dyslipoproteinemia in systemic lupus erythematosus. Effects of corticosteroids, American Journal of Medicine, 83, 503, 10.1016/0002-9343(87)90762-5 Felson, 1984, Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis, New England Journal of Medicine, 311, 1528, 10.1056/NEJM198412133112402 Fink, 1995, Successful treatment of interstitial lung disease in systemic lupus erythematosus with methotrexate, Journal of Rheumatology, 22, 967 Formiga, 1995, Loss of bone mineral density in premenopausal women with systemic lupus erythematosus, Annals of the Rheumatic Diseases, 54, 274, 10.1136/ard.54.4.274 Formiga Perez, 1993, Infection and systemic lupus erythematosus: analysis of a series of 145 patients, Revista Clinica Espanola, 193, 105 Friedman, 1965, Effect of cortisone on lipid and cholesterol metabolism in the rabbit and rat, American Journal of Physiology, 208, 94, 10.1152/ajplegacy.1965.208.1.94 Furie, 1988, Tendon rupture in systemic lupus erythematosus, Seminars in Arthritis and Rheumatism, 18, 127, 10.1016/0049-0172(88)90005-4 Gennari, 1997, Arginine, glutamine, and dehydroepiandrosterone reverse the immunosuppressive effect of prednisone during gut-derived sepsis, Critical Care Medicine, 25, 1207, 10.1097/00003246-199707000-00024 Ginzler, 1975, Long-term maintenance therapy with azathioprine in systemic lupus erythematosus, Arthritis and Rheumatism, 18, 27, 10.1002/art.1780180106 Ginzler, 1978, Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus, Arthritis and Rheumatism, 21, 37, 10.1002/art.1780210107 Gladman, 1987, Morbidity in systemic lupus erythematosus, Journal of Rheumatology, 14, 223 Glynne-Jones, 1986, Is steroid psychosis preventable by divided doses?, Lancet, ii, 1404, 10.1016/S0140-6736(86)92051-9 Graham, 1993, Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs, Annals of Internal Medicine, 119, 257, 10.7326/0003-4819-119-4-199308150-00001 Haider, 1981, Coronary arterial disease in systemic lupus erythematosus. Quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years, American Journal of Medicine, 70, 775, 10.1016/0002-9343(81)90532-5 Hashimoto, 1994, Methotrexate for steroid-resistant systemic lupus erythematosus, Clinical Rheumatology, 13, 280 Hepburn, 1996, Reduction of anti-dsDNA antibodies using LJP394 in patients with lupus, Arthritis and Rheumatism, 39, S307 Hesselink, 1993, An evaluation of risk factors in incisional hernia recurrence, Surgery, Gynecology and Obstetrics, 176, 228 Hodis, 1993, The lipid, lipoprotein, and apolipoprotein effects of hydroxchloroquine in patients with systemic lupus erythematosus, Journal of Rheumatology, 20, 661 Hosenpud, 1984, Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus, American Journal of Medicine, 77, 286, 10.1016/0002-9343(84)90704-6 Ilowite, 1988, Dyslipoproteinemia in pediatric systemic lupus erythematosus, Arthritis and Rheumatism, 31, 859, 10.1002/art.1780310706 Ilowite, 1995, Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus, Journal of Rheumatology, 22, 1347 Kalla, 1993, Loss of trabecular bone mineral density in systemic lupus erythematosus, Arthritis and Rheumatism, 36, 1726, 10.1002/art.1780361212 Kanayama, 1981, Correlation between steroid myopathy and serum lactic dehydrogenase in systemic lupus erythematosus, Archives of Internal Medicine, 141, 1176, 10.1001/archinte.1981.00340090072017 Keystone, 1996, Biologic agents in autoimmune disease, Journal of Rheumatology, 23, 743 Kipen, 1997, Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids, Journal of Rheumatology, 24, 1922 Kojima, 1996, Inhibition of steroid-induced cataract in rat eyes by administration of vitamin-E ophthalmic solution, Ophthalmic Research, 28, 64, 10.1159/000267958 Lance, 1991, Bullous skin lesions in systemic lupus erythematosus, Seminars in Arthritis and Rheumatism, 20, 396, 10.1016/0049-0172(91)90015-R Lane, 1995, Prevention and management of glucocorticoid-induced osteoporosis, Bulletin on the Rheumatic Diseases, 44, 1 Leong, 1994, Lipid profiles in patients with systemic lupus erythematosus, Journal of Rheumatology, 21, 1264 McMurray, 1995, Efficacy of bromocriptine in an open label trial for systemic lupus erythematosus, Journal of Rheumatology, 22, 2084 Massardo, 1992, High-dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus, Lupus, 1, 401, 10.1177/096120339200100610 Meller, 1975, Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus, American Journal of Cardiology, 35, 309, 10.1016/0002-9149(75)90019-3 Messer, 1983, Association of adrenocorticosteroid therapy and peptic ulcer disease, New England Journal of Medicine, 309, 21, 10.1056/NEJM198307073090105 Migliaresi, 1994, Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies, Lupus, 3, 37, 10.1177/096120339400300108 Mont, 1997, Risk factors for osteonecrosis in systemic lupus erythematosus, Journal of Rheumatology, 24, 654 Nayak, 1996, The efficacy of antimalarials in systemic lupus erythematosus, Lupus, 5, S23, 10.1177/096120339600500106 Niwa, 1994, Abnormalities in serum lipids and leukocyte superoxide dismutase and associated cataract formation in patients with atopic dermatitis, Archives of Dermatology, 130, 1387, 10.1001/archderm.1994.01690110053006 Olefsky, 1976, Effects of glucocorticoids on carbohydrate metabolism, American Journal of the Medical Sciences, 271, 202, 10.1097/00000441-197603000-00009 Paulino-Netto, 1960, Pancreatitis in disseminated lupus erythematosus, Journal of Mount Sinai Hospital, 27, 291 Petri, 1995, Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update, Arthritis Care and Research, 8, 137, 10.1002/art.1790080305 Petri, 1997, Frequency of atherosclerosis detected by carotid duplex in SLE, Arthritis and Rheumatism, 40, 219 Petri, 1992, Risk factors for coronary artery disease in patients with systemic lupus erythematosus, American Journal of Medicine, 93, 513, 10.1016/0002-9343(92)90578-Y Petri, 1994, Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis, American Journal of Medicine, 96, 254, 10.1016/0002-9343(94)90151-1 Phillips, 1992, Effects of chronic corticosteroids and vitamin A on the healing of intestinal anastomoses, American Journal of Surgery, 163, 71, 10.1016/0002-9610(92)90255-P Piper, 1991, Corticosteroid use and peptic ulcer disease. Role of antiinflammatory drugs, Annals of Internal Medicine, 114, 735, 10.7326/0003-4819-114-9-735 Pistiner, 1991, Lupus erythematosus in the 1980s: a survey of 570 patients, Seminars in Arthritis and Rheumatism, 21, 55, 10.1016/0049-0172(91)90057-7 Pons, 1995, The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in premenopausal women, British Journal of Rheumatology, 34, 742, 10.1093/rheumatology/34.8.742 Pritchard, 1989, Patellar tendon rupture in systemic lupus erythematosus, Journal of Rheumatology, 16, 786 Punch, 1995, Corticosteroid withdrawal after liver transplantation, Surgery, 118, 783, 10.1016/S0039-6060(05)80050-9 Rahman, 1997, Effect of antimalarials on serum cholesterol in SLE, Arthritis and Rheumatism, 40, S303 Renfro, 1992, Ocular effects of topical and systemic steroids, Dermatologic Clinics, 10, 505, 10.1016/S0733-8635(18)30318-8 Ritchlin, 1989, Opportunistic infections in patients with systemic lupus erythematosus, Arthritis and Rheumatism, 32, S115 Rosner, 1982, A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death, Arthritis and Rheumatism, 25, 612, 10.1002/art.1780250602 Saab, 1998, Corticosteroids and systemic lupus erythematosus pancreatitis: case series and review of the literature, Journal of Rheumatology, 25, 801 Schäfers, 1992, Preoperative corticosteroids. A contra-indication to lung transplantation?, Chest, 102, 1522, 10.1378/chest.102.5.1522 Smith, 1966, Corticosteroid glaucoma: a summary and review of the literature, American Journal of the Medical Sciences, 252, 239, 10.1097/00000441-196608000-00017 Soffer, 1952, Corticotropin and cortisone in acute disseminated lupus erythematosus: results of long term use, Journal of the American Medical Association, 149, 1002, 10.1001/jama.1952.02930280024007 Staples, 1974, Incidence of infection in systemic lupus erythematosus, Arthritis and Rheumatism, 17, 1, 10.1002/art.1780170102 Stern, 1973, Adrenocortical steroid treatment of rheumatic diseases—effects on lipid metabolism, Archives of Internal Medicine, 132, 97, 10.1001/archinte.1973.03650070083013 Sudhir, 1989, Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function, Hypertension, 13, 416, 10.1161/01.HYP.13.5.416 Sultan, 1994, Lack of evidence for corticosteroids as a risk factor for coronary artery disease in systemic lupus erythematosus Taskinen, 1988, Short-term effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men, Journal of Clinical Endocrinology and Metabolism, 67, 291, 10.1210/jcem-67-2-291 Thomas, 1987, Antiinsulin antibodies and clinical characteristics of patients with systemic lupus erythematosus and other connective tissue diseases with steroid induced diabetes, Journal of Rheumatology, 14, 732 Tincani, 1996, International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations, Clinical and Experimental Rheumatology, 14, S23 Tsakraklides, 1974, Coronary atherosclerosis and myocardial infarction with systemic lupus erythematosus, American Heart Journal, 87, 637, 10.1016/0002-8703(74)90504-3 Urowitz, 1976, The bimodal mortality pattern of systemic lupus erythematosus, American Journal of Medicine, 60, 221, 10.1016/0002-9343(76)90431-9 van Vollenhoven, 1995, Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial, Arthritis and Rheumatism, 38, 1826, 10.1002/art.1780381216 Wallace, 1990, Cholesterol lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids, American Journal of Medicine, 89, 322, 10.1016/0002-9343(90)90345-E Walton, 1991, Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus, Annals of the Rheumatic Diseases, 50, 463, 10.1136/ard.50.7.463 Wang, 1977, Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits, Journal of Bone and Joint Surgery (American), 59, 729, 10.2106/00004623-197759060-00003 Watanabe Duffy, 1991, Infection and disease activity in SLE: a review of hospitalized patients, Journal of Rheumatology, 18, 1180 Weiner, 1989, Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation, Journal of Rheumatology, 16, 604 Weinstock-Guttman, 1996, Neurologic complications of immunosuppressive and anti-inflammatory therapy for rheumatic diseases, Journal of Clinical Rheumatology, 2, 268, 10.1097/00124743-199610000-00007 Werth, 1997, Glucocorticoid-induced osteoporosis. Evaluation, prevention, and treatment, Journal of Clinical Rheumatology, 3, S69, 10.1097/00124743-199704001-00016 West, 1988, Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus, Annals of Internal Medicine, 108, 703, 10.7326/0003-4819-108-5-703 Wilke, 1991, Methotrexate for systemic lupus erythematosus: a retrospective analysis of 17 unselected cases, Clinical and Experimental Rheumatology, 9, 581 Wilson, 1994, A 2 year, open ended trial of methotrexate in systemic lupus erythematosus, Journal of Rheumatology, 21, 1674 Zhou, 1996, Using a lipid clearing drug to prevent osteocytes damage of the femoral head in steroid-treated rabbits, Chinese Medical Journal, 76, 13 Zimmerman, 1984, The effect of prednisone therapy on plasma lipoproteins and apolipoproteins; a prospective study, Metabolism, 33, 521, 10.1016/0026-0495(84)90006-4 Zizic, 1985, Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus, American Journal of Medicine, 79, 596, 10.1016/0002-9343(85)90057-9